(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

Englisch Name:: (11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

Synonyma:: 1',2'-f][1,3,2]dioxaphosphepin;(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d;(11bR)-2,6-Di([1,1'-biphenyl]-4-yl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxid;(11bR)-2,6-Di([1,1'-biphenyl]-4-yl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide;(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;(11b-R)-2,6-di([1,1'-biphenyl)-4-yl)-8,9,10,1,12,13,14,15-octahydro-4-hydroxy-4-oxy-dinaphthalenebenzo[2,1-D:1',2'-F][1,3,2]]dioxyphosphino;(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,1 5-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1, 3,2]dioxaphosphepin,99%e.e.;Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bR)- (9CI);(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 30

(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin Eigenschaften

Sicherheit

Bildanzeige (GHS)

Alarmwort

Warnung

Gefahrenhinweise

Code	Gefahrenhinweise	Gefahrenklasse	Abteilung	Alarmwort	P-Code
H302	Gesundheitssch?dlich bei Verschlucken.	Akute Toxizit?t oral	Kategorie 4	Warnung	P264, P270, P301+P312, P330, P501
H315	Verursacht Hautreizungen.	Hautreizung	Kategorie 2	Warnung	P264, P280, P302+P352, P321,P332+P313, P362
H319	Verursacht schwere Augenreizung.	Schwere Augenreizung	Kategorie 2	Warnung	P264, P280, P305+P351+P338,P337+P313P
H335	Kann die Atemwege reizen.	Spezifische Zielorgan-Toxizit?t (einmalige Exposition)	Kategorie 3 (Atemwegsreizung)	Warnung

Sicherheit

P280	Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P305+P351+P338	BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen.

Global( 30)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shanghai Daken Advanced Materials Co.,Ltd	+86-2158073036	info@dakenam.com	China	14014	58
Aladdin Scientific		tp@aladdinsci.com	United States	57505	58
Daicel Chiral Technologies (China)CO.,LTD	021-50460086-9 15921403865	han_yajun@dctc.daicel.com	China	7831	65
Tianjin Derchemist Science & Technology Co., Ltd.	22-58627059 13920586291	zdcomcon@126.com	China	4095	50
Shanghai Chiral bio-compound co., Ltd.	021-5068 3667/17749785980/1029026415; 17749785980	1029026415@qq.com	China	4359	58
Shanghai YuanYe Biotechnology Co., Ltd.	13636370518	shyysw007@163.com	China	89686	60
NanJing Xienuo bio Co.,Ltd.	025-84112752 13805181430	154301870@qq.com	China	1000	55
Zhengzhou Huiju Chemical Co., Ltd.	0371-55900031 18137872243	3927209986@qq.com	China	9995	55
LaaJoo	021-60702684 18516024827	huang.jiayi@sinocompound.com	China	2280	58
Greenherbs Science and Technology Development Co., Ltd.	010-61136123	pub02@greenherbs.com.cn	China	4049	58

(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,1 5-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1, 3,2]dioxaphosphepin,99%e.e.
(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d
1',2'-f][1,3,2]dioxaphosphepin
(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bR)- (9CI)
(11bR)-2,6-Di([1,1'-biphenyl]-4-yl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
(11bR)-2,6-Di([1,1'-biphenyl]-4-yl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxid
(11b-R)-2,6-di([1,1'-biphenyl)-4-yl)-8,9,10,1,12,13,14,15-octahydro-4-hydroxy-4-oxy-dinaphthalenebenzo[2,1-D:1',2'-F][1,3,2]]dioxyphosphino
861909-35-5
C44H37O4P